HK1139604A1 - Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound - Google Patents

Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound

Info

Publication number
HK1139604A1
HK1139604A1 HK10106360.7A HK10106360A HK1139604A1 HK 1139604 A1 HK1139604 A1 HK 1139604A1 HK 10106360 A HK10106360 A HK 10106360A HK 1139604 A1 HK1139604 A1 HK 1139604A1
Authority
HK
Hong Kong
Prior art keywords
heart failure
chronic heart
compound
methyl
therapeutic agent
Prior art date
Application number
HK10106360.7A
Other languages
English (en)
Inventor
Jee-Hyun Shin
Gook Jun Ahn
Kyung-Koo Kang
Byoung-Ok Ahn
Moo-Hi Yoo
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Publication of HK1139604A1 publication Critical patent/HK1139604A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK10106360.7A 2007-06-09 2010-06-29 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound HK1139604A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020070056392A KR101002490B1 (ko) 2007-06-09 2007-06-09 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
PCT/KR2008/003101 WO2008153282A1 (en) 2007-06-09 2008-06-03 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound

Publications (1)

Publication Number Publication Date
HK1139604A1 true HK1139604A1 (en) 2010-09-24

Family

ID=40129865

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106360.7A HK1139604A1 (en) 2007-06-09 2010-06-29 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound

Country Status (23)

Country Link
US (1) US20100173915A1 (zh)
EP (1) EP2167093B1 (zh)
JP (1) JP5249321B2 (zh)
KR (1) KR101002490B1 (zh)
CN (1) CN101678027B (zh)
AT (1) ATE553762T1 (zh)
AU (1) AU2008262794B2 (zh)
BR (1) BRPI0812492A2 (zh)
CA (1) CA2689438C (zh)
CO (1) CO6270326A2 (zh)
CY (1) CY1113380T1 (zh)
DK (1) DK2167093T3 (zh)
ES (1) ES2384668T3 (zh)
HK (1) HK1139604A1 (zh)
IL (1) IL202400A0 (zh)
MX (1) MX2009013342A (zh)
MY (1) MY144993A (zh)
NZ (1) NZ582158A (zh)
PT (1) PT2167093E (zh)
RU (1) RU2420289C1 (zh)
UA (1) UA96340C2 (zh)
WO (1) WO2008153282A1 (zh)
ZA (1) ZA201000094B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657828B (zh) * 2012-03-21 2013-06-05 李秀环 一种治疗慢性心衰的药物组合物
CN103356671B (zh) * 2013-06-24 2015-11-25 顾祥茂 Houttuynoid C在制备治疗或预防慢性心衰的药物中的应用
TN2017000029A1 (en) 2014-08-12 2018-07-04 Mezzion Pharma Co Ltd Methods of improving myocardial performance in fontan patients using udenafil compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
KR100324911B1 (ko) * 1999-03-08 2002-02-28 조민호 피라졸로피리미디논 유도체와 이의 제조방법그리고 이의 용도
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
KR100358083B1 (ko) * 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
AU2005224043B2 (en) * 2004-03-05 2010-06-24 Takeda Gmbh Novel use for PDE5 inhibitors
US20070031349A1 (en) * 2005-06-23 2007-02-08 David Monteith Rapidly absorbing oral formulations of PDE 5 inhibitors
WO2007067570A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease

Also Published As

Publication number Publication date
CN101678027A (zh) 2010-03-24
CY1113380T1 (el) 2016-06-22
CA2689438A1 (en) 2008-12-18
CN101678027B (zh) 2012-05-09
CO6270326A2 (es) 2011-04-20
MY144993A (en) 2011-12-15
MX2009013342A (es) 2010-01-25
AU2008262794B2 (en) 2011-04-14
NZ582158A (en) 2012-01-12
CA2689438C (en) 2012-06-05
UA96340C2 (ru) 2011-10-25
BRPI0812492A2 (pt) 2014-12-02
EP2167093A1 (en) 2010-03-31
ATE553762T1 (de) 2012-05-15
ZA201000094B (en) 2010-09-29
IL202400A0 (en) 2010-06-30
KR101002490B1 (ko) 2010-12-17
US20100173915A1 (en) 2010-07-08
JP5249321B2 (ja) 2013-07-31
PT2167093E (pt) 2012-06-15
RU2420289C1 (ru) 2011-06-10
EP2167093A4 (en) 2010-08-11
ES2384668T3 (es) 2012-07-10
EP2167093B1 (en) 2012-04-18
DK2167093T3 (da) 2012-06-25
WO2008153282A1 (en) 2008-12-18
AU2008262794A1 (en) 2008-12-18
JP2010529113A (ja) 2010-08-26
KR20080108185A (ko) 2008-12-12

Similar Documents

Publication Publication Date Title
MX2021008358A (es) Lipidos para la administracion de agentes activos en nanoparticulas lipidicas.
WO2010011375A3 (en) Inhibitors of janus kinases
WO2006018182A8 (en) Combinations for the treatment of diseases involving cell proliferation
WO2009076170A3 (en) Combinations of therapeutic agents for treating cancer
WO2011113802A3 (en) Imidazopyridine and purine compounds, compositions and methods of use
HK1139604A1 (en) Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
CL2008001364A1 (es) Uso de compuestos derivados de imidazol(1,2-b) piridazina y pirazolo(1,5-a) pirimidina inhibidores de tirosina quinasa pi-para tratar tumor benigno o maligno, entre otros; compuestos dereivados de imidazol(1,2-b)piridazina y pirazolo(1,5-a)pirimidina; composiciones farmaceuticas; y metodo de preparacion de compuestos.
MY134589A (en) Imidazopyrazines as cyclin dependent kinase inhibitors
WO2004026310A8 (en) Novel imidazopyrazines as cyclin dependent kinase inhibitors
WO2007061764A3 (en) Tricyclic compounds useful as inhibitors of kinases
WO2005077450A3 (en) Intravascular delivery system for therapeutic agents
WO2007058873A3 (en) Imidazopyrazines as cyclin depentend kinase inhibitors
WO2006053161A8 (en) Use ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
UA106378C2 (ru) Производные фенилимидазола как ингибиторы фермента pde10a
WO2006032115A3 (en) Composition against cardiovascular diseases
NZ752918A (en) Treatment of prostate cancer
KR20180002657A (ko) 전신 경화증 (SSc)에 수반되는 수족지 궤양 (DU)의 치료를 위한 sGC 자극제, sGC 활성화제 단독 및 PDE5 억제제와의 조합물의 용도
MXPA05007333A (es) Composiciones farmaceuticas.
WO2006115770A3 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
NZ591204A (en) Pharmaceutical compositions and methods for stabilizing the same
TW200420554A (en) A intra-airway administrating preparation
WO2016167622A3 (ko) 나프토퀴논계 화합물을 유효성분으로 포함하는 췌장염 예방 및 치료용 조성물
MX2021009550A (es) Inhibidor de la quinasa atr para usar en el tratamiento de una enfermedad hiperproliferativa.
CA3242402A1 (en) Lipids for use in lipid nanoparticle formulations
WO2005062874A3 (en) Compounds and compositions for delivering active agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160603